Achalasia and Dysplasia

March 19, 2026 updated by: Guy Boeckxstaens, KU Leuven

Screening for Dysplasia in Longstanding Idiopathic Achalasia: a Prospective Study

Patient with achalasia have a 10-50 fold increased risk to develop esophageal squamous cell carcinoma (ESCC). Early diagnosis of ESCC is essential, and detection of an earlier dysplastic stage is preferred. Endoscopic detection is however difficult and often delayed. Chromoendoscopy with Lugol dye increases detection rates dysplasia and ESCC to 91-100%. The aim of this study was therefore to evaluate a screening program using chromoendoscopy with Lugol to detect dysplasia in patients with idiopathic achalasia.

A second objective is to study the relationship between foodstasis and the development op dysplasia

Study Overview

Study Type

Interventional

Enrollment (Actual)

39

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Leuven, Belgium, 3000
        • UZLeuven

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • longstanding achalasia (> 15y)
  • > 18y old
  • informed consent

Exclusion Criteria:

  • allergy to iodine
  • esophageal carcinoma

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: N/A
  • Interventional Model: Single Group Assignment

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: longstanding achalasia
chromoendoscopy (lugol stain and virtual chromoendoscopy)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
incidence of dysplasia in patients with longstanding achalasia
Time Frame: 1 year
1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
additive value of chromoendoscopy in comparison with lugol stain
Time Frame: 1 year
1 year
relationship between food stasis and dysplasia
Time Frame: 1 year
  • relationship between elevated LES pressure and dysplasia
  • relationship between stasis on EndoFLIP and dysplasia
  • relationship between stasis on timed barium esophagogram and dysplasia
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2013

Primary Completion (Actual)

December 19, 2016

Study Completion (Actual)

December 19, 2016

Study Registration Dates

First Submitted

February 14, 2013

First Submitted That Met QC Criteria

December 12, 2013

First Posted (Estimated)

December 13, 2013

Study Record Updates

Last Update Posted (Actual)

March 20, 2026

Last Update Submitted That Met QC Criteria

March 19, 2026

Last Verified

March 1, 2026

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dysplasia in Longstanding Achalasia

Clinical Trials on chromoendoscopy

Subscribe